The Main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII
De Filippis V., Pagotto A., Uliana F., Nordio G., Pierangelini A., Acquasaliente L., Macchia ML., Bellanda M., Gatto B., De Silvestro G., Marson P., Simioni P., Picotti P.